Risk of Operational Suspensions and Deteriorating Business Performance Due to COVID-19
First written in FY2020. 5 of 13 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.
- FY2026DroppedAnnual reportThe principal risks in this filing do not identify COVID-19 as a separate risk item.
- FY2024-Q3MitigatedAnnual report
「Although personal consumption and inbound demand have continued to recover as the post-COVID trend has accelerated,」
Regarding economic activity following the lifting of restrictions due to COVID-19, the disclosure has changed to state that the post-COVID trend has accelerated and that personal consumption and inbound demand are recovering. - FY2024-Q1MitigatedAnnual report
「Although personal consumption and inbound demand are showing signs of recovery against the backdrop of the easing of restrictions on activity following COVID-19's reclassification as a Class 5 infectious disease,」
The disclosure has changed to state that economic activity is showing signs of recovery against the backdrop of COVID-19's reclassification as a Class 5 infectious disease and the easing of activity restrictions. - FY2023-Q1MitigatedAnnual report
「During the first quarter of the current consolidated fiscal year, the global economic environment surrounding the Group continued to show signs of recovery against the backdrop of eased restrictions on activity due to COVID-19, although」
The disclosure has changed to state that, as restrictions on activity due to COVID-19 have been eased, the global economy is maintaining its recovery trend. - FY2022RestatedAnnual report
「For the fiscal year ending March 2022, restrictions on social and economic activity were eased in various countries as vaccination against COVID-19 progressed. However, the timing of the end of the pandemic remains uncertain, and if the situation continues for an extended period or infections spread further, the Group's operating performance and financial position may be adversely affected.」
While acknowledging the easing of activity restrictions, the disclosure continues to note the possibility that a prolonged or renewed spread of the infection could affect operating performance and financial position. - FY2022-Q3RestatedAnnual report
「In Japan, recovery has continued, with exports and capital investment demand across the manufacturing sector increasing against the backdrop of eased activity restrictions as vaccination has progressed. However, concerns over a renewed spread of infections caused by new variants persist, and the situation remains unpredictable.」
While acknowledging the easing of activity restrictions and the recovery in capital investment demand, the disclosure continues to express concern over a renewed spread of infections caused by new variants. - FY2022-Q2RestatedAnnual report
「In Japan, capital investment and production activity, particularly in the manufacturing sector, showed signs of recovery, and exports continued to trend upward. However, intermittent waves of infections and restrictions have made it impossible to foresee when economic activity overall will return to normal.」
While acknowledging the recovery in manufacturing and the increase in exports, the disclosure continues to point to uncertainty over the normalization of economic activity due to intermittent waves of infections and restrictions. - FY2022-Q1RestatedAnnual report
「Concern over a renewed spread of infections caused by variant viruses」
Regarding COVID-19, the disclosure continues to note that vaccination and the resumption of economic activity are positive factors, while also expressing concern over a renewed spread of infections caused by variant viruses. - FY2021MaterialisedAnnual report
「In the fiscal year ended March 2021, the spread of COVID-19 severely restricted social and economic activity in countries around the world and had a serious impact on the economy, while lockdowns forced the Group’s overseas factories to suspend production.」
The Company explicitly states that COVID-19-related production stoppages at overseas factories and restrictions on social and economic activity occurred as part of the fiscal-year results. - FY2021-Q3WorsenedAnnual report
「However, although the Group’s overseas factories, whose operations had been suspended by the lockdown in the first quarter, shifted to increased production from the second quarter onward and contributed to sales, social and economic activity remained severely restricted in countries around the world, including Japan, due to the resurgence of COVID-19, resulting in continued difficult conditions.」
In addition to the suspension of operations at overseas factories and the subsequent increase in production, restrictions on social and economic activity in countries around the world due to the resurgence of infections have continued. The impact of the risk has become more concrete through the resurgence. - FY2021-Q2RestatedAnnual report
「However, although overseas plants of the Group were shut down due to the lockdown in the first quarter and production was increased from the second quarter, contributing to sales, economic activity in Japan and Western countries was severely restricted by the spread of COVID-19, and conditions remained difficult.」
The Company continues to describe the impact of COVID-19-related suspensions of operations at overseas factories and restrictions on economic activity. The shift to increased production and its contribution to sales are also described. - FY2021-Q1MaterialisedAnnual report
「Meanwhile, the Company was significantly affected by the spread of COVID-19, including the temporary forced suspension of operations at overseas factories.」
The temporary suspension of operations at overseas factories due to COVID-19 also occurred during the quarter, leading to shipment delays and deteriorating operating performance. - FY2020First statedAnnual report
「The Group was also significantly affected, including by the forced suspension of operations at its factories in China and the Philippines.」
The Company has for the first time described the actual suspension of operations at its factories in China and the Philippines, and the potential for a prolonged outbreak and further spread of COVID-19 to adversely affect operating performance and financial position, as a standalone risk.